Findings seen among men with very high-risk prostate cancer<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Aug. 16, 2023 (HealthDay News) — Among men with very high-risk prostate cancer, higher radiation facility case volume is independently associated with longer overall survival, according to a study published online Aug. 8 in JAMA Network Open<\/em>.<\/p>\n Nikhil Sebastian, M.D., from Emory University in Atlanta, and colleagues examined differences in outcomes between patients with very high-risk prostate cancer treated at radiation facilities with high versus low patient volume. The analysis included 25,219 men identified from the National Cancer Database.<\/p>\n The researchers found that 25.5 percent of men were treated at facilities with high average cumulative volume. During a median of 57.4 months of follow-up, median overall survival was 123.4 months for men treated at high-volume centers versus 109.0 months for those treated at low-volume centers. Further, treatment at a high-volume center was associated with a lower risk for death (hazard ratio, 0.89). Results remained significant after inverse probability score weight-based adjustment.<\/p>\n “These findings suggest that the expertise and resources that accompany high-volume treatment facilities are associated with improved outcomes for men with very high-risk prostate cancer, but further investigation is needed to identify the specific causes for this association,” the authors write.<\/p>\n